Vir Biotechnology (VIR) Intangibles (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Intangibles data on file, last reported at $7.8 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 3.65% year-over-year to $7.8 million; the trailing twelve-month figure through Mar 2026 stood at $7.8 million (down 3.65% YoY), and the FY2025 full-year result was $7.8 million, down 3.33% from the prior year.
• Intangibles slipped to $7.8 million in Q1 2026, from $7.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $33.2 million in Q1 2022 to a low of $7.8 million in Q1 2026.
• A 5-year average of $20.4 million and a median of $22.5 million in 2024 frame the typical range for Intangibles.
• Across the five-year window, Intangibles declined 1.58% in 2022 and tumbled 64.07% in 2025, its largest moves.
• Tracing VIR's Intangibles over 5 years: stood at $32.8 million in 2022, then plunged by 31.11% to $22.6 million in 2023, then slumped by 64.02% to $8.1 million in 2024, then retreated by 3.33% to $7.8 million in 2025, then dropped by 0.93% to $7.8 million in 2026.
• Business Quant data shows VIR's Intangibles at $7.8 million in Q1 2026, $7.8 million in Q4 2025, and $7.9 million in Q3 2025.